|
gptkbp:instanceOf
|
contraceptive implant
|
|
gptkbp:activeIngredient
|
gptkb:etonogestrel
|
|
gptkbp:approvedBy
|
gptkb:FDA
birth control
|
|
gptkbp:ATCCode
|
G03AC08
|
|
gptkbp:brand
|
etonogestrel implant
|
|
gptkbp:compatibleWith
|
oral contraceptive
|
|
gptkbp:contains
|
gptkb:barium_sulfate
|
|
gptkbp:contraindication
|
gptkb:liver_disease
known or suspected pregnancy
active thrombosis
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:detects
|
gptkb:X-rays
|
|
gptkbp:diameter
|
2 mm
|
|
gptkbp:effect
|
up to 3 years
|
|
gptkbp:form
|
rod
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nexplanon
|
|
gptkbp:insertedBy
|
gptkb:physician
|
|
gptkbp:insertionSite
|
inner side of upper arm
|
|
gptkbp:legalStatus
|
Rx-only
|
|
gptkbp:length
|
4 cm
|
|
gptkbp:manufacturer
|
gptkb:Organon
|
|
gptkbp:marketedAs
|
2011
|
|
gptkbp:mechanismOfAction
|
inhibits ovulation
thickens cervical mucus
thins endometrium
|
|
gptkbp:notRecommendedFor
|
women with unexplained vaginal bleeding
women with breast cancer
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:removalRecommendedAfter
|
3 years
|
|
gptkbp:removalSite
|
inner side of upper arm
|
|
gptkbp:removes
|
gptkb:physician
|
|
gptkbp:replacedBy
|
Implanon
new Nexplanon implant
|
|
gptkbp:riskFactor
|
gptkb:migration
expulsion
infection
scarring
insertion complications
|
|
gptkbp:routeOfAdministration
|
subdermal
|
|
gptkbp:sideEffect
|
headache
breast tenderness
acne
weight gain
irregular bleeding
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:bfsParent
|
gptkb:Organon_(2021_spin-off)
gptkb:Organon_&_Co._(2021)
|
|
gptkbp:bfsLayer
|
6
|